Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model.

To address the growing demand of small-diameter vascular grafts for cardiovascular disease, it is necessary to develop substitutes with bio-functionalities, such as anticoagulation, rapid endothelialization, and smooth muscle regeneration. In this study, the small-diameter tubular grafts (2.2 mm) were fabricated by electrospinning of biodegradable polymer polycaprolactone (PCL) followed by functional surface coating with an arginine-glycine-aspartic acid (RGD)-containing molecule. The healing characteristics of the grafts were evaluated by implanting them in rabbit carotid arteries for 2 and 4 weeks. Results showed that at both time points, all 10 of the RGD-modified PCL grafts (PCL-RGD) were patent, whereas 4 of the 10 non-modified PCL grafts were occluded due to thrombus formation. Scanning electron microscopy (SEM) data showed abundant platelets adhering on the surface of the midportion of the PCL grafts. In contrast, only few platelets were observed on the PCL-RGD surface, suggesting that RGD modification significantly improved the hemocompatibility of the PCL grafts. Histological analysis demonstrated enhanced cell infiltration and homogeneous distribution within the PCL-RGD grafts in comparison with the PCL grafts. Furthermore, immunofluorescence staining also showed a 3-fold increase of endothelial coverage of the PCL-RGD grafts than that of PCL grafts at those two time points. After 4-week implantation, 65.3 ± 7.6% of the surface area of the PCL-RGD grafts was covered by smooth muscle cell layer, which is almost 23% more than that on the PCL grafts. The present study indicates that RGD-modified PCL grafts exhibit an improved remodeling and integration capability in revascularization.

[1]  A. Seifalian,et al.  Development of a hybrid cardiovascular graft using a tissue engineering approach 1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Gavin Jell,et al.  Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. , 2008, Biomacromolecules.

[3]  A. Seifalian,et al.  Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  E. Place,et al.  Complexity in biomaterials for tissue engineering. , 2009, Nature materials.

[5]  S. Stupp,et al.  Branched peptide-amphiphiles as self-assembling coatings for tissue engineering scaffolds. , 2006, Journal of Biomedical Materials Research. Part A.

[6]  Qiang Zhao,et al.  Immobilization of anti-CD31 antibody on electrospun poly(ɛ-caprolactone) scaffolds through hydrophobins for specific adhesion of endothelial cells. , 2011, Colloids and surfaces. B, Biointerfaces.

[7]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[8]  Kwideok Park,et al.  Enhanced dermal wound neovascularization by targeted delivery of endothelial progenitor cells using an RGD-g-PLLA scaffold. , 2009, Biomaterials.

[9]  Min Yang,et al.  Implantation of decellularized small-caliber vascular xenografts with and without surface heparin treatment. , 2007, Artificial organs.

[10]  Gerhard Ziemer,et al.  Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization--a review of current strategies. , 2010, Biotechnology advances.

[11]  G. Striker,et al.  The origin of post-injury neointimal cells in the rat balloon injury model. , 2009, Cardiovascular research.

[12]  James J. Yoo,et al.  Bilayered scaffold for engineering cellularized blood vessels. , 2010, Biomaterials.

[13]  Anthony Atala,et al.  The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. , 2009, Biomaterials.

[14]  H. Erickson,et al.  Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. , 1993, Journal of cell science.

[15]  N. Krott,et al.  A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. , 2006, Journal of the American College of Cardiology.

[16]  Christopher Breuer,et al.  Artificial blood vessel: the Holy Grail of peripheral vascular surgery. , 2005, Journal of vascular surgery.

[17]  Nikolaos Stergiopulos,et al.  RGD-Functionalized polymer brushes as substrates for the integrin specific adhesion of human umbilical vein endothelial cells. , 2007, Biomaterials.

[18]  Hongwei Wang,et al.  Fabrication and properties of the electrospun polylactide/silk fibroin-gelatin composite tubular scaffold. , 2009, Biomacromolecules.

[19]  Song Li,et al.  Regulation of endothelial cell function by GRGDSP peptide grafted on interpenetrating polymers. , 2007, Journal of biomedical materials research. Part A.

[20]  Alexander M Seifalian,et al.  The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. , 2004, Biomaterials.

[21]  Song Li,et al.  Antithrombogenic Modification of Small-Diameter Microfibrous Vascular Grafts , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[22]  D. Bezuidenhout,et al.  Prosthetic vascular grafts: wrong models, wrong questions and no healing. , 2007, Biomaterials.

[23]  David L Kaplan,et al.  Gel spinning of silk tubes for tissue engineering. , 2008, Biomaterials.

[24]  M. Chan-Park,et al.  Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. , 2009, Journal of biomedical materials research. Part A.

[25]  M. Grinstaff,et al.  Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion. , 2011, Biomacromolecules.

[26]  David G Simpson,et al.  A three-layered electrospun matrix to mimic native arterial architecture using polycaprolactone, elastin, and collagen: a preliminary study. , 2010, Acta biomaterialia.

[27]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[28]  David A. Vorp,et al.  A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend. , 2009, Biomaterials.

[29]  Mingyan Yang,et al.  Enhancing growth human endothelial cells on Arg-Gly-Asp (RGD) embedded poly (epsilon-caprolactone) (PCL) surface with nanometer scale of surface disturbance. , 2005, Journal of biomedical materials research. Part A.

[30]  M. Sumi,et al.  Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material. , 2010, Journal of vascular surgery.

[31]  Robert Gurny,et al.  Degradation and Healing Characteristics of Small-Diameter Poly(&egr;-Caprolactone) Vascular Grafts in the Rat Systemic Arterial Circulation , 2008, Circulation.

[32]  E. Falk,et al.  Flanking Recipient Vasculature, Not Circulating Progenitor Cells, Contributes to Endothelium and Smooth Muscle in Murine Allograft Vasculopathy , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[33]  F. Xu,et al.  Surface functionalization of polycaprolactone films via surface-initiated atom transfer radical polymerization for covalently coupling cell-adhesive biomolecules. , 2010, Biomaterials.

[34]  Qingbo Xu,et al.  Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells , 2002, Circulation.

[35]  D. Hutmacher,et al.  The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .

[36]  Horst Kessler,et al.  RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. , 2003, Biomaterials.

[37]  Qiang Zhao,et al.  Highly stable surface modifications of poly(3-caprolactone) (PCL) films by molecular self-assembly to promote cells adhesion and proliferation. , 2011, Chemical communications.

[38]  David F. Williams.  The role of short synthetic adhesion peptides in regenerative medicine; the debate. , 2011, Biomaterials.

[39]  R. Nagai,et al.  Diverse Contribution of Bone Marrow Cells to Neointimal Hyperplasia After Mechanical Vascular Injuries , 2003, Circulation research.

[40]  Narutoshi Hibino,et al.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling , 2010, Proceedings of the National Academy of Sciences.

[41]  Howard P. Greisler,et al.  Growing a living blood vessel: insights for the second hundred years. , 2007, Biomaterials.

[42]  Roberta Cortivo,et al.  In vivo regeneration of small‐diameter (2 mm) arteries using a polymer scaffold , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Adinarayana Andukuri,et al.  A hybrid biomimetic scaffold composed of electrospun polycaprolactone nanofibers and self-assembled peptide amphiphile nanofibers , 2009, Biofabrication.

[44]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[45]  Changyou Gao,et al.  Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. , 2002, Biomacromolecules.

[46]  C C Canver,et al.  Conduit options in coronary artery bypass surgery. , 1995, Chest.

[47]  V. V. van Hinsbergh,et al.  Direct grafting of RGD-motif-containing peptide on the surface of polycaprolactone films , 2006, Journal of biomaterials science. Polymer edition.